Never Pay Procedures Under APG Reimbursement
Revised for January 1, 2024 Updates:
- Also available in Excel Format (XLS) and Portable Document Format (PDF)
Information revised during the quarterly update period stated above is highlighted.
Px Code | Procedure (Px) Description | Alternative Payment Available |
Date Added to Never Pay List |
Date Removed from Never Pay List |
Date subsequently added to Never Pay List |
---|---|---|---|---|---|
20696 | Comp multiplane ext fixation | No | 01/01/13 | ||
20697 | Comp ext fixate strut change | No | 01/01/13 | ||
20983 | Ablate bone tumor(s) perq | No | 07/01/16 | ||
20985 | Cptr-asst dir ms px | No | 12/01/08 | ||
20986 | Cptr-asst dir ms px io img | No | 12/01/08 | ||
20987 | Cptr-asst dir ms px pre img | No | 12/01/08 | ||
22867 | Insj stablj dev w/dcmprn | No | 01/01/17 | ||
22868 | Insj stablj dev w/dcmprn | No | 01/01/17 | ||
22869 | Insj stablj dev w/o dcmprn | No | 01/01/17 | ||
22870 | Insj stablj dev w/o dcmprn | No | 01/01/17 | ||
27412 | Autochondrocyte implant knee | No | 07/01/10 | ||
28890 | High energy eswt, plantar f | No | 12/01/08 | ||
32994 | Ablate pulm tumor perq crybl | No | 07/01/18 | ||
36473 | Endovenous mchnchem 1st vein | No | 01/01/17 | ||
36474 | Endovenous mchnchem add-on | No | 01/01/17 | ||
36482 | Endoven ther chem adhes 1st | No | 07/01/18 | ||
36483 | Endoven ther chem adhes sbsq | No | 07/01/18 | ||
43257 | Uppr gi scope w/thrml txmnt | No | 07/01/10 | ||
43284 | Laps esophgl sphnctr agmntj | No | 01/01/17 | ||
43285 | Rmvl esophgl sphnctr dev | No | 01/01/17 | ||
55400 | Repair of sperm duct | No | 04/01/13 | ||
55706 | Prostate saturation sampling | No | 07/01/10 | ||
55874 | Tprnl plmt biodegrdabl matrl | No | 07/01/18 | ||
58750 | Repair oviduct | No | 10/01/09 | ||
59610 | Vbac delivery | No | 01/01/20 | ||
62380 | Ndsc dcmprn 1 ntrspc lumbar | No | 01/01/17 | ||
64912 | Nrv rpr w/nrv algrft 1st | No | 07/01/18 | ||
64913 | Nrv rpr w/nrv algrft ea addl | No | 07/01/18 | ||
65785 | Impltj ntrstrml crnl rng seg | No | 01/01/18 | ||
70554 | Fmri brain by tech | No | 12/01/08 | ||
74261 | Ct colonography dx | No | 04/01/11 | ||
74262 | Ct colonography dx w/dye | No | 04/01/11 | ||
74263 | Ct colonography screening | No | 04/01/11 | ||
75571 | Ct hrt w/o dye w/ca test | No | 04/01/11 | ||
75572 | Ct hrt w/3d image | No | 04/01/11 | ||
75573 | Ct hrt w/3d image congen | No | 04/01/11 | ||
75574 | Ct angio hrt w/3d image | No | 04/01/11 | 07/01/16 | |
77082 | Dxa bone density vert fx | No | 10/01/12 | 01/01/15 | |
77422 | Neutron beam tx, simple | No | 04/01/09 | 07/01/10 | |
77423 | Neutron beam tx, complex | No | 04/01/09 | 07/01/10 | |
81161 | Dmd dup/delet analysis | No | 01/01/15 | ||
81200 | Aspa gene | No | 01/01/16 | ||
81201 | Apc gene full sequence | No | 01/01/16 | ||
81202 | Apc gene known fam variants | No | 01/01/16 | ||
81203 | Apc gene dup/delet variants | No | 01/01/16 | ||
81205 | Bckdhb gene | No | 01/01/16 | ||
81206 | Bcr/abl1 gene major bp | No | 01/01/16 | ||
81207 | Bcr/abl1 gene minor bp | No | 01/01/16 | ||
81208 | Bcr/abl1 gene other bp | No | 01/01/16 | ||
81209 | Blm gene | No | 01/01/16 | ||
81210 | Braf gene | No | 01/01/16 | ||
81211 | Brca1&2 seq & com dup/del | No | 01/01/16 | ||
81212 | Brca1&2 185&5385&6174 var | No | 01/01/16 | ||
81213 | Brca1&2 uncom dup/del var | No | 01/01/16 | ||
81214 | Brca1 full seq & com dup/del | No | 01/01/16 | ||
81215 | Brca1 gene known fam variant | No | 01/01/16 | ||
81216 | Brca2 gene full sequence | No | 01/01/16 | ||
81217 | Brca2 gene known fam variant | No | 01/01/16 | ||
81220 | Cftr gene com variants | No | 01/01/16 | ||
81221 | Cftr gene known fam variants | No | 01/01/16 | ||
81222 | Cftr gene dup/delet variants | No | 01/01/16 | ||
81223 | Cftr gene full sequence | No | 01/01/16 | ||
81224 | Cftr gene intron poly t | No | 01/01/16 | ||
81225 | Cyp2c19 gene com variants | No | 01/01/16 | ||
81226 | Cyp2d6 gene com variants | No | 01/01/16 | ||
81227 | Cyp2c9 gene com variants | No | 01/01/16 | ||
81228 | Cytogen micrarray copy nmbr | No | 01/01/16 | ||
81229 | Cytogen m array copy no&snp | No | 01/01/16 | ||
81235 | Egfr gene com variants | No | 01/01/16 | ||
81240 | F2 gene | No | 01/01/16 | ||
81241 | F5 gene | No | 01/01/16 | ||
81242 | Fancc gene | No | 01/01/16 | ||
81243 | Fmr1 gene detection | No | 01/01/16 | ||
81244 | Fmr1 gene characterization | No | 01/01/16 | ||
81245 | Flt3 gene | No | 01/01/16 | ||
81246 | Flt3 gene analysis | No | 01/01/16 | ||
81250 | G6pc gene | No | 01/01/16 | ||
81251 | Gba gene | No | 01/01/16 | ||
81252 | Gjb2 gene full sequence | No | 01/01/16 | ||
81253 | Gjb2 gene known fam variants | No | 01/01/16 | ||
81254 | Gjb6 gene com variants | No | 01/01/16 | ||
81255 | Hexa gene | No | 01/01/16 | ||
81256 | Hfe gene | No | 01/01/16 | ||
81257 | Hba1/hba2 gene | No | 01/01/16 | ||
81260 | Ikbkap gene | No | 01/01/16 | ||
81261 | Igh gene rearrange amp meth | No | 01/01/16 | ||
81262 | Igh gene rearrang dir probe | No | 01/01/16 | ||
81263 | Igh vari regional mutation | No | 01/01/16 | ||
81264 | Igk rearrangeabn clonal pop | No | 01/01/16 | ||
81265 | Str markers specimen anal | No | 01/01/16 | ||
81266 | Str markers spec anal addl | No | 01/01/16 | ||
81267 | Chimerism anal no cell selec | No | 01/01/16 | ||
81268 | Chimerism anal w/cell select | No | 01/01/16 | ||
81270 | Jak2 gene | No | 01/01/16 | ||
81275 | Kras gene | No | 01/01/16 | ||
81280 | Long qt synd gene full seq | No | 01/01/16 | ||
81281 | Long qt synd known fam var | No | 01/01/16 | ||
81282 | Long qt syn gene dup/dlt var | No | 01/01/16 | ||
81287 | Mgmt gene methylation anal | No | 01/01/16 | ||
81288 | Mlh1 gene | No | 01/01/16 | ||
81290 | Mcoln1 gene | No | 01/01/16 | ||
81291 | Mthfr gene | No | 01/01/16 | ||
81292 | Mlh1 gene full seq | No | 01/01/16 | ||
81293 | Mlh1 gene known variants | No | 01/01/16 | ||
81294 | Mlh1 gene dup/delete variant | No | 01/01/16 | ||
81295 | Msh2 gene full seq | No | 01/01/16 | ||
81296 | Msh2 gene known variants | No | 01/01/16 | ||
81297 | Msh2 gene dup/delete variant | No | 01/01/16 | ||
81298 | Msh6 gene full seq | No | 01/01/16 | ||
81299 | Msh6 gene known variants | No | 01/01/16 | ||
81300 | Msh6 gene dup/delete variant | No | 01/01/16 | ||
81301 | Microsatellite instability | No | 01/01/16 | ||
81302 | Mecp2 gene full seq | No | 01/01/16 | ||
81303 | Mecp2 gene known variant | No | 01/01/16 | ||
81304 | Mecp2 gene dup/delet variant | No | 01/01/16 | ||
81310 | Npm1 gene | No | 01/01/16 | ||
81313 | Pca3/klk3 antigen | No | 01/01/16 | ||
81315 | Pml/raralpha com breakpoints | No | 01/01/16 | ||
81316 | Pml/raralpha 1 breakpoint | No | 01/01/16 | ||
81317 | Pms2 gene full seq analysis | No | 01/01/16 | ||
81318 | Pms2 known familial variants | No | 01/01/16 | ||
81319 | Pms2 gene dup/delet variants | No | 01/01/16 | ||
81321 | Pten gene full sequence | No | 01/01/16 | ||
81322 | Pten gene known fam variant | No | 01/01/16 | ||
81323 | Pten gene dup/delet variant | No | 01/01/16 | ||
81324 | Pmp22 gene dup/delet | No | 01/01/16 | ||
81325 | Pmp22 gene full sequence | No | 01/01/16 | ||
81326 | Pmp22 gene known fam variant | No | 01/01/16 | ||
81327 | Sept9 methylation analysis | No | 01/01/17 | 07/01/18 | |
81330 | Smpd1 gene common variants | No | 01/01/16 | ||
81331 | Snrpn/ube3a gene | No | 01/01/16 | ||
81332 | Serpina1 gene | No | 01/01/16 | ||
81340 | Trb@ gene rearrange amplify | No | 01/01/16 | ||
81341 | Trb@ gene rearrange dirprobe | No | 01/01/16 | ||
81342 | Trg gene rearrangement anal | No | 01/01/16 | ||
81350 | Ugt1a1 gene | No | 01/01/16 | ||
81355 | Vkorc1 gene | No | 01/01/16 | ||
81370 | Hla i & ii typing lr | No | 01/01/16 | ||
81371 | Hla i & ii type verify lr | No | 01/01/16 | ||
81372 | Hla i typing complete lr | No | 01/01/16 | ||
81373 | Hla i typing 1 locus lr | No | 01/01/16 | ||
81374 | Hla i typing 1 antigen lr | No | 01/01/16 | ||
81375 | Hla ii typing ag equiv lr | No | 01/01/16 | ||
81376 | Hla ii typing 1 locus lr | No | 01/01/16 | ||
81377 | Hla ii type 1 ag equiv lr | No | 01/01/16 | ||
81378 | Hla i & ii typing hr | No | 01/01/16 | ||
81379 | Hla i typing complete hr | No | 01/01/16 | ||
81380 | Hla i typing 1 locus hr | No | 01/01/16 | ||
81381 | Hla i typing 1 allele hr | No | 01/01/16 | ||
81382 | Hla ii typing 1 loc hr | No | 01/01/16 | ||
81383 | Hla ii typing 1 allele hr | No | 01/01/16 | ||
81400 | Mopath procedure level 1 | No | 01/01/16 | ||
81401 | Mopath procedure level 2 | No | 01/01/16 | ||
81402 | Mopath procedure level 3 | No | 01/01/16 | ||
81403 | Mopath procedure level 4 | No | 01/01/16 | ||
81404 | Mopath procedure level 5 | No | 01/01/16 | ||
81405 | Mopath procedure level 6 | No | 01/01/16 | ||
81406 | Mopath procedure level 7 | No | 01/01/16 | ||
81407 | Mopath procedure level 8 | No | 01/01/16 | ||
81408 | Mopath procedure level 9 | No | 01/01/16 | ||
81410 | Aortic dysfunction/dilation | No | 01/01/16 | ||
81411 | Aortic dysfunction/dilation | No | 01/01/16 | ||
81415 | Exome sequence analysis | No | 01/01/16 | ||
81416 | Exome sequence analysis | No | 01/01/16 | ||
81417 | Exome re-evaluation | No | 01/01/16 | ||
81420 | Fetal chrmoml aneuploidy | No | 01/01/16 | ||
81422 | Fetal chrmoml microdeltj | No | 01/01/17 | 07/01/18 | |
81425 | Genome sequence analysis | No | 01/01/16 | ||
81426 | Genome sequence analysis | No | 01/01/16 | ||
81427 | Genome re-evaluation | No | 01/01/16 | ||
81430 | Hearing loss sequence analys | No | 01/01/16 | ||
81431 | Hearing loss dup/del analys | No | 01/01/16 | ||
81435 | Hereditary colon cancer | No | 01/01/16 | ||
81436 | Hereditary colon ca synd | No | 01/01/16 | ||
81439 | Inherited cardmypthy 5 gns | No | 01/01/17 | 07/01/18 | |
81440 | Mitochondrial gene | No | 01/01/16 | ||
81445 | Targeted genomic seq analys | No | 01/01/16 | ||
81450 | Targeted genomic seq analys | No | 01/01/16 | ||
81455 | Targeted genomic seq analys | No | 01/01/16 | ||
81460 | Whole mitochondrial genome | No | 01/01/16 | ||
81465 | Whole mitochondrial genome | No | 01/01/16 | ||
81470 | X-linked intellectual dblt | No | 01/01/16 | ||
81471 | X-linked intellectual dblt | No | 01/01/16 | ||
81479 | Unlisted molecular pathology | No | 01/01/16 | ||
81500 | Onco (ovar) two proteins | No | 01/01/16 | ||
81503 | Onco (ovar) five proteins | No | 01/01/16 | ||
81504 | Oncology tissue of origin | No | 01/01/16 | ||
81506 | Endo assay seven anal | No | 01/01/16 | ||
81507 | Fetal aneuploidy trisom risk | No | 01/01/16 | ||
81508 | Ftl cgen abnor two proteins | No | 01/01/16 | ||
81509 | Ftl cgen abnor 3 proteins | No | 01/01/16 | ||
81510 | Ftl cgen abnor three anal | No | 01/01/16 | ||
81511 | Ftl cgen abnor four anal | No | 01/01/16 | ||
81512 | Ftl cgen abnor five anal | No | 01/01/16 | ||
81519 | Oncology breast mrna | No | 01/01/16 | ||
81539 | Oncology prostate prob score | No | 01/01/17 | 07/01/18 | |
81599 | Unlisted maaa | No | 01/01/16 | ||
83655 | Assay of lead | No | 12/01/08 | ||
83722 | Lipoprtn dir meas sd ldl chl | No | 07/01/19 | ||
83890 | Molecule isolate | No | 01/01/10 | ||
83891 | Molecule isolate nucleic | No | 01/01/10 | ||
83892 | Molecular diagnostics | No | 01/01/10 | ||
83893 | Molecule dot/slot/blot | No | 01/01/10 | ||
83894 | Molecule gel electrophor | No | 01/01/10 | ||
83896 | Molecular diagnostics | No | 01/01/10 | ||
83897 | Molecule nucleic transfer | No | 01/01/10 | ||
83898 | Molecule nucleic ampli, each | No | 01/01/10 | ||
83900 | Molecule nucleic ampli 2 seq | No | 01/01/10 | ||
83901 | Molecule nucleic ampli addon | No | 01/01/10 | ||
83902 | Molecular diagnostics | No | 01/01/10 | ||
83903 | Molecule mutation scan | No | 01/01/10 | ||
83904 | Molecule mutation identify | No | 01/01/10 | ||
83905 | Molecule mutation identify | No | 01/01/10 | ||
83906 | Molecule mutation identify | No | 01/01/10 | ||
83907 | Lyse cells for nucleic ext | No | 01/01/10 | ||
83908 | Nucleic acid, signal ampli | No | 01/01/10 | ||
83909 | Nucleic acid, high resolute | No | 01/01/10 | ||
83912 | Genetic examination | No | 01/01/10 | ||
83913 | Molecular, rna stabilization | No | 01/01/10 | ||
83914 | Mutation ident ola/sbce/aspe | No | 01/01/10 | ||
84410 | Testosterone bioavailable | No | 01/01/17 | 07/01/18 | |
85004 | Automated diff wbc count | No | 10/01/09 | ||
85610 | Prothrombin time | No | 10/01/09 | ||
86008 | Allg spec ige recomb ea | No | 07/01/18 | ||
86328 | Ia nfct ab sarscov2 covid 19 | Yes | 04/01/20 | ||
86408 | Neutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID19]); screen | No | 07/01/20 | ||
86409 | Neutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID19]); titer | No | 07/01/20 | ||
86413 | Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (Coronavirus disease [COVID-19]) antibody, quantitative | No | 07/01/20 | ||
86769 | Sars-cov-2 covid-19 antibody | Yes | 04/01/20 | ||
86794 | Zika virus igm antibody | No | 07/01/18 | ||
86849 | Immunology procedure | No | 04/01/12 | ||
87426 | Coronavirus ag ia | Yes | 04/01/20 | ||
87483 | Cns dna amp probe type 12-25 | No | 01/01/17 | ||
87536 | Hiv-1, dna, quant | No | 12/01/08 | ||
87539 | Hiv-2, dna, quant | No | 04/01/10 | ||
87593 | Orthopoxvirus amp prb each | Yes | 01/01/23 | ||
87634 | Rsv dna/rna amp probe | No | 07/01/18 | ||
87635 | Sars-cov-2 covid-19 amp prb | Yes | 01/01/20 | ||
87636 | Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) and influenza virus types A and B, multiplex amplified probe technique | Yes | 07/01/20 | ||
87637 | Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), influenza virus types A and B, and respiratory syncytial virus, multiplex amplified probe technique | Yes | 07/01/20 | ||
87662 | Zika virus dna/rna amp probe | No | 07/01/18 | ||
87811 | Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) | Yes | 07/01/20 | ||
87900 | Virtual phenotype | No | 01/01/10 | ||
87901 | GeNo - APG Carve Outtype, dna, hiv reverse t | No | 12/01/08 | ||
87902 | GeNo - APG Carve Outtype, dna, hepatitis C | No | 12/01/08 | ||
87903 | PheNo - APG Carve Outtype, dna hiv w/culture | No | 12/01/08 | ||
87904 | PheNo - APG Carve Outtype, dna hiv w/clt add | No | 10/01/09 | ||
87913 | Nfct agt gntyp alys sarscov2 | No | 01/01/21 | ||
87999 | Microbiology procedure | No | 12/01/08 | ||
88230 | Tissue culture, lymphocyte | No | 01/01/10 | ||
88233 | Tissue culture, skin/biopsy | No | 01/01/10 | ||
88235 | Tissue culture, placenta | No | 01/01/10 | ||
88237 | Tissue culture, bone marrow | No | 01/01/10 | ||
88239 | Tissue culture, tumor | No | 01/01/10 | ||
88240 | Cell cryopreserve/storage | No | 01/01/10 | ||
88241 | Frozen cell preparation | No | 01/01/10 | ||
88245 | Chromosome analysis, 20-25 | No | 01/01/10 | ||
88248 | Chromosome analysis, 50-100 | No | 01/01/10 | ||
88249 | Chromosome analysis, 100 | No | 01/01/10 | ||
88261 | Chromosome analysis, 5 | No | 01/01/10 | ||
88262 | Chromosome analysis, 15-20 | No | 01/01/10 | ||
88263 | Chromosome analysis, 45 | No | 01/01/10 | ||
88264 | Chromosome analysis, 20-25 | No | 01/01/10 | ||
88267 | Chromosome analys, placenta | No | 01/01/10 | ||
88269 | Chromosome analys, amniotic | No | 01/01/10 | ||
88271 | Cytogenetics, dna probe | No | 01/01/10 | ||
88272 | Cytogenetics, 3-5 | No | 01/01/10 | ||
88273 | Cytogenetics, 10-30 | No | 01/01/10 | ||
88274 | Cytogenetics, 25-99 | No | 01/01/10 | ||
88275 | Cytogenetics, 100-300 | No | 01/01/10 | ||
88280 | Chromosome karyotype study | No | 01/01/10 | ||
88283 | Chromosome banding study | No | 01/01/10 | ||
88285 | Chromosome count, additional | No | 01/01/10 | ||
88289 | Chromosome study, additional | No | 01/01/10 | ||
88291 | Cyto/molecular report | No | 01/01/10 | ||
88299 | Cytogenetic study | No | 01/01/16 | ||
88323 | Microslide consultation | No | 01/01/21 | ||
88325 | Comprehensive review of data | No | 01/01/21 | ||
88331 | Path consult intraop 1 bloc | No | 01/01/21 | ||
88332 | Path consult intraop addl | No | 01/01/21 | ||
88333 | Intraop cyto path consult 1 | No | 01/01/21 | ||
88334 | Intraop cyto path consult 2 | No | 01/01/21 | ||
88375 | Optical endomicroscpy interp | No | 01/01/21 | ||
89250 | Cultr oocyte/embryo <4 days | No | 01/01/21 | ||
89251 | Cultr oocyte/embryo <4 days | No | 01/01/21 | ||
89253 | Embryo hatching | No | 01/01/21 | ||
89254 | Oocyte identification | No | 01/01/21 | ||
89255 | Prepare embryo for transfer | No | 01/01/21 | ||
89257 | Sperm identification | No | 01/01/21 | ||
89258 | Cryopreservation embryo(s) | No | 01/01/21 | ||
89259 | Cryopreservation sperm | No | 01/01/21 | ||
89260 | Sperm isolation simple | No | 01/01/21 | ||
89261 | Sperm isolation complex | No | 01/01/21 | ||
89264 | Identify sperm tissue | No | 01/01/21 | ||
89268 | Insemination of oocytes | No | 01/01/21 | ||
89272 | Extended culture of oocytes | No | 01/01/21 | ||
89280 | Assist oocyte fertilization | No | 01/01/21 | ||
89281 | Assist oocyte fertilization | No | 01/01/21 | ||
89290 | Biopsy oocyte polar body | No | 01/01/21 | ||
89291 | Biopsy oocyte polar body | No | 01/01/21 | ||
89335 | Cryopreserve testicular tiss | No | 01/01/21 | ||
89337 | Cryopreservation oocyte(s) | No | 01/01/21 | ||
89342 | Storage/year embryo(s) | No | 01/01/21 | ||
89343 | Storage/year sperm/semen | No | 01/01/21 | ||
89344 | Storage/year reprod tissue | No | 01/01/21 | ||
89346 | Storage/year oocyte(s) | No | 01/01/21 | ||
89352 | Thawing cryopresrved embryo | No | 01/01/21 | ||
89353 | Thawing cryopresrved sperm | No | 01/01/21 | ||
89354 | Thaw cryoprsvrd reprod tiss | No | 01/01/21 | ||
89356 | Thawing cryopresrved oocyte | No | 01/01/21 | ||
90375 | Rabies ig im/sc | Yes | 07/01/17 | ||
90376 | Rabies ig heat treated | Yes | 07/01/17 | ||
90470 | H1N1 Administration | No | 10/01/09 | 07/01/11 | |
90473 | Immune admin oral/nasal | Yes | 10/01/09 | 04/01/11 | |
90480 | IMMUNIZATION ADMINISTRATION BY INTRAMUSCULAR INJECTION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARSCOV-2) (CORONAVIRUS DISEASE [COVID-19]) VACCINE, SINGLE DOSE | Yes | 07/01/23 | ||
90655 | Flu vaccine no preserv 6-35m | Yes | 10/01/09 | 04/01/11 | |
90656 | Flu vaccine no preserv 3 & > | Yes | 10/01/09 | 04/01/11 | |
90657 | Flu vaccine, 3 yrs, im | Yes | 10/01/09 | 04/01/11 | |
90658 | Flu vaccine, 3 yrs & >, im | Yes | 10/01/09 | 04/01/11 | |
90660 | Flu vaccine, nasal | Yes | 10/01/09 | 04/01/11 | |
90663 | Flu vacc pandemic | No | 10/01/09 | 07/01/11 | |
90669 | Pneumococcal vacc, ped <5 | No | 10/01/09 | 04/01/11 | |
90732 | Pneumococcal vaccine | Yes | 10/01/09 | 04/01/11 | |
90750 | Hzv vacc recombinant im njx | N/A | 01/01/17 | 07/01/18 | |
90785 | Psytx complex interactive | No | 01/01/21 | ||
90863 | Pharmacologic mgmt w/psytx | No | 04/01/13 | ||
90875 | Psychophysiological therapy | No | 07/01/10 | ||
90876 | Psychophysiological therapy | No | 07/01/10 | ||
90880 | Hypnotherapy | No | 04/01/09 | ||
90901 | Biofeedback train, any meth | No | 07/01/10 | ||
90911 | Biofeedback peri/uro/rectal | No | 07/01/10 | 01/01/20 | |
90951 | Esrd serv 4 visits p mo <2yr | No | 01/01/20 | ||
90952 | Esrd serv 2-3 vsts p mo <2yr | No | 01/01/20 | ||
90953 | Esrd serv 1 visit p mo <2yrs | No | 01/01/20 | ||
90954 | Esrd serv 4 vsts p mo 2-11 | No | 01/01/20 | ||
90955 | Esrd srv 2-3 vsts p mo 2-11 | No | 01/01/20 | ||
90956 | Esrd srv 1 visit p mo 2-11 | No | 01/01/20 | ||
90957 | Esrd srv 4 vsts p mo 12-19 | No | 01/01/20 | ||
90958 | Esrd srv 2-3 vsts p mo 12-19 | No | 01/01/20 | ||
90959 | Esrd serv 1 vst p mo 12-19 | No | 01/01/20 | ||
90960 | Esrd srv 4 visits p mo 20+ | No | 01/01/20 | ||
90961 | Esrd srv 2-3 vsts p mo 20+ | No | 01/01/20 | ||
90962 | Esrd serv 1 visit p mo 20+ | No | 01/01/20 | ||
90963 | Esrd home pt serv p mo <2yrs | No | 01/01/20 | ||
90964 | Esrd home pt serv p mo 2-11 | No | 01/01/20 | ||
90965 | Esrd home pt serv p mo 12-19 | No | 01/01/20 | ||
90966 | Esrd home pt serv p mo 20+ | No | 01/01/20 | ||
91300 | SARSCOV2 VAC 30MCG/0.3ML IM | No | 01/01/21 | ||
91301 | SARSCOV2 VAC 100MCG/0.5ML IM | No | 01/01/21 | ||
91302 | SARSCOV2 VAC 5X10^10VP/.5MLIM | No | 01/01/21 | ||
91303 | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x1010 viral particles/0.5mL dosage, for intramuscular use | No | 01/01/21 | ||
91304 | SARSCOV2 VAC 5MCG/0.5ML IM | Yes | 01/01/21 | ||
91305 | SARSCOV2 VAC 30 MCG TRS-SUCR | No | 01/01/21 | ||
91306 | SARSCOV2 VAC 50MCG/0.25ML IM | No | 01/01/21 | ||
91307 | vaccine (age 5-11) | No | 01/01/21 | ||
91312 | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use | No | 07/01/22 | ||
91313 | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosage, for intramuscular use | No | 07/01/22 | ||
91314 | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 25 mcg/0.25 mL dosage, for intramuscular use | No | 07/01/22 | ||
91315 | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular us | No | 07/01/22 | ||
91316 | Sarscov2 vac bvl 10mcg/0.2ml | No | 01/01/23 | ||
91317 | Sarscov2 vac bvl 3mcg/0.2ml | No | 01/01/23 | ||
91318 | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 3 mcg/0.3 mL dose | Yes | 07/01/23 | ||
91319 | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 10 mcg/0.3 mL dose | Yes | 07/01/23 | ||
91320 | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 30 mcg/0.3 mL dose | Yes | 07/01/23 | ||
91321 | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 25 mcg/0.25 mL dose | Yes | 07/01/23 | ||
91322 | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose | Yes | 07/01/23 | ||
92145 | Corneal hysteresis deter | No | 07/01/16 | ||
92973 | Prq coronary mech thrombect | No | 01/01/20 | ||
93702 | Bis xtracell fluid analysis | No | 07/01/16 | ||
93895 | Carotid intima atheroma eval | No | 07/01/16 | ||
94625 | Phy/qhp op pulm rhb w/o mntr | Yes | 01/01/22 | ||
94626 | Phy/qhp op pulm rhb w/mntr | Yes | 01/01/22 | ||
94664 | Evaluate pt use of inhaler | No | 10/01/16 | ||
95012 | Exhaled nitric oxide meas | No | 12/01/08 | ||
95800 | Slp stdy unattended | No | 01/01/13 | ||
95801 | Slp stdy unatnd w/anal | No | 01/01/13 | ||
95806 | Sleep study unatt&resp efft | No | 01/01/13 | ||
95965 | Meg, spontaneous | No | 12/01/08 | 07/01/16 | |
95966 | Meg, evoked, single | No | 12/01/08 | 07/01/16 | |
96102 | Psycho testing by technician | No | 04/01/09 | 04/01/10 | |
96119 | Neuropsych testing by tec | No | 04/01/09 | 04/01/10 | |
96127 | Brief emotional/behav assmt | No | 07/01/16 | ||
96131 | Psycl tst eval phys/qhp ea | No | 07/01/19 | ||
96133 | Nrpsyc tst eval phys/qhp ea | No | 07/01/19 | ||
96146 | Psycl/nrpsyc tst auto result | No | 07/01/19 | ||
96373 | Ther/proph/diag inj ia | No | 01/01/20 | ||
96374 | Ther/proph/diag inj iv push | No | 01/01/20 | ||
96375 | Tx/pro/dx inj new drug addon | No | 01/01/20 | ||
96376 | Tx/pro/dx inj same drug adon | No | 01/01/20 | ||
97012 | Mechanical traction therapy | No | 04/01/13 | ||
97124 | Massage therapy | No | 04/01/09 | 07/01/10 | |
97150 | Group therapeutic procedures | No | 04/01/09 | 04/01/10 | |
97154 | Grp adapt bhv tx by tech | Yes | 07/01/23 | ||
97157 | Mult fam adapt bhv tx gdn | Yes | 07/01/23 | ||
97169 | Athletic trn eval low cmplx | No | 01/01/17 | ||
97170 | Athletic trn eval mod cmplx | No | 01/01/17 | ||
97171 | Athletic trn eval high cmplx | No | 01/01/17 | ||
97172 | Athletic trn re-eval plan cr | No | 01/01/17 | ||
97610 | Low frequency non-thermal us | No | 07/01/16 | ||
97810 | Acupunct w/o stimul 15 min | No | 04/01/09 | ||
97811 | Acupunct w/o stimul addl 15m | No | 04/01/09 | ||
97813 | Acupunct w/stimul 15 min | No | 04/01/09 | ||
97814 | Acupunct w/stimul addl 15m | No | 04/01/09 | ||
98940 | Chiropractic manipulation | No | 01/01/12 | ||
98941 | Chiropractic manipulation | No | 04/01/11 | ||
98942 | Chiropractic manipulation | No | 01/01/12 | ||
98943 | Chiropractic manipulation | No | 01/01/12 | ||
99002 | Device Handling | No | 04/01/11 | ||
99072 | Additional supplies, materials, and clinical staff time over and above those usually included in an office visit or other nonfacility service(s), when performed during a Public Health Emergency, as defined by law, due to respiratory-transmitted infectious disease | No | 07/01/20 | ||
0001A | ADM SARSCOV2 30MCG/0.3ML 1ST | No | 01/01/21 | ||
0002A | ADM SARSCOV2 30MCG/0.3ML 2ND | No | 01/01/21 | ||
0003A | ADM SARSCOV2 30MCG/0.3ML 3RD | No | 01/01/21 | ||
0004A | ADM SARSCOV2 30MCG/0.3ML BST | No | 01/01/21 | ||
0004M | Scoliosis dna alys | No | 01/01/16 | ||
0006M | Onc hep gene risk classifier | No | 01/01/16 | ||
0006U | Rx mntr 120+ drugs & sbsts | No | 07/01/18 | ||
0007M | Onc gastro 51 gene nomogram | No | 01/01/16 | ||
0007U | Rx test prsmv ur w/def conf | No | 07/01/18 | ||
0008M | Onc breast risk score | No | 01/01/16 | ||
0008U | Hpylori detcj abx rstnc dna | No | 07/01/18 | ||
0009M | Fetal aneuploidy trisom risk | No | 01/01/16 | 01/01/20 | |
0010M | Onc Prostate prob score | No | 01/01/16 | ||
0011A | ADM SARSCOV2 100MCG/0.5ML1ST | No | 01/01/21 | ||
0011U | Rx mntr lc-ms/ms oral fluid | No | 07/01/18 | ||
0012A | ADM SARSCOV2 100MCG/0.5ML2ND | No | 01/01/21 | ||
0013A | ADM SARSCOV2 100MCG/0.5ML3RD | No | 01/01/21 | ||
0019T | Extracorp shock wv tx,ms nos | No | 04/01/10 | 01/01/17 | |
0020U | Rx test prsmv ur w/def conf | No | 07/01/18 | ||
0021A | ADM SARSCOV2 5X10^10VP/.5ML 1 | No | 01/01/21 | ||
0022A | ADM SARSCOV2 5X10^10VP/.5ML 2 | No | 01/01/21 | ||
0031A | Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x1010 viral particles/0.5mL dosage, single dose | No | 01/01/21 | ||
0034A | IMM ADMN SARSCOV2 AD26 5X1010 VP/0.5 ML BST DOSE | No | 01/01/21 | ||
0038U | Vitamin d srm microsamp quan | No | 07/01/19 | ||
0041A | ADM SARSCOV2 5MCG/0.5ML 1ST | No | 01/01/21 | ||
0041U | B brgdrferi antb 5 prtn igm | No | 07/01/19 | ||
0042A | ADM SARSCOV2 5MCG/0.5ML 2ND | No | 01/01/21 | ||
0042U | B brgdrferi antb 12 prtn igg | No | 07/01/19 | ||
0043U | Tbrf b grp antb 4 prtn igm | No | 07/01/19 | ||
0044U | Tbrf b grp antb 4 prtn igg | No | 07/01/19 | ||
0051A | ADM SARSCV2 30MCG TRS-SUCR 1 | No | 01/01/21 | ||
0052A | ADM SARSCV2 30MCG TRS-SUCR 2 | No | 01/01/21 | ||
0053A | ADM SARSCV2 30MCG TRS-SUCR 3 | No | 01/01/21 | ||
0054A | ADM SARSCV2 30MCG TRS-SUCR B | No | 01/01/21 | ||
0058U | Onc merkel cll carc srm quan | No | 07/01/19 | ||
0059U | Onc merkel cll carc srm +/- | No | 07/01/19 | ||
0061U | Tc meas 5 bmrk sfdi m-s alys | No | 07/01/19 | ||
0064A | ADM SARSCOV2 50MCG/0.25MLBST | No | 01/01/21 | ||
0064U | Antb tp total&rpr ia qual | No | 07/01/19 | ||
0066U | Pamg-1 ia cervico-vag fluid | No | 07/01/19 | ||
0071A | 1st dose | No | 01/01/21 | ||
0072A | 2nd dose | No | 01/01/21 | ||
0073A | Adm sarscv2 10mcg trs-sucr 3 | No | 01/01/23 | ||
0074A | Adm sarscv2 10mcg trs-sucr b | No | 01/01/23 | ||
0077U | Ig paraprotein qual bld/ur | No | 07/01/19 | ||
0081A | ADM SARSCOV2 3 MCG/0.2 ML TRS-SUCR 1st dose | No | 07/01/22 | ||
0082A | ADM SARSCOV2 3 MCG/0.2 ML TRS-SUCR 2nd dose | No | 07/01/22 | ||
0083A | ADM SARSCOV2 3 MCG/0.2 ML TRS-SUCR 3rd dose | No | 07/01/22 | ||
0086U | Nfct ds bact&fng org id 6+ | No | 07/01/20 | ||
0091A | ADM SARSCOV2 50 MCG/.5 ML 1st dose | No | 07/01/22 | ||
0091U | Onc clrct scr whl bld alg | No | 07/01/20 | ||
0092A | ADM SARSCOV2 50 MCG/.5 ML 2nd dose | No | 07/01/22 | ||
0093A | ADM SARSCOV2 50 MCG/.5 ML 3rd dose | No | 07/01/22 | ||
0094A | Moderna – ADM SARSCOV2 N/A 50MCG/0.5 ML – Booster Dose | No | 07/01/22 | ||
0096U | Hpv hi risk types male urine | No | 07/01/20 | ||
0097U | Gi pathogen 22 targets | No | 07/01/20 | ||
0098U | Respir pathogen 14 targets | No | 07/01/20 | ||
0099U | Respir pathogen 20 targets | No | 07/01/20 | ||
0100U | Respir pathogen 21 targets | No | 07/01/20 | ||
0106U | Gstr emptg 7 timed brth spec | No | 07/01/20 | ||
0109U | Id aspergillus dna 4 species | No | 07/01/20 | ||
0111A | ADM SARSCOV2 25MCG/0.25ML 1st dose | No | 07/01/22 | ||
0112A | ADM SARSCOV2 25MCG/0.25ML 2nd dose | No | 07/01/22 | ||
0112U | Iadi 16s&18s rrna genes | No | 07/01/20 | ||
0113A | ADM SARSCOV2 25MCG/0.25ML 3rd dose | No | 07/01/22 | ||
0115U | Respir iadna 18 viral&2 bact | No | 07/01/20 | ||
0119U | Crd ceramides liq chrom plsm | No | 01/01/22 | ||
0121A | ADM SARSCOV2 Bivalent 30MCG/0.3ML – 1st Dose | No | 01/01/23 | ||
0121U | Sc dis vcam-1 whole blood | No | 07/01/20 | ||
0122U | Sc dis p-selectin whl blood | No | 07/01/20 | ||
0124A | Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, booster dose | No | 07/01/22 | ||
0126T | Chd risk imt study | No | 01/01/13 | ||
0134A | Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosage, booster dose | No | 07/01/22 | ||
0140U | Nfct ds fungi dna 15 trgt | No | 07/01/20 | ||
0141A | ADM SARSCOV2 Bivalent 25MCG/0.25ML – 1st Dose | No | 01/01/23 | ||
0141U | Nfct ds bact&fng gram pos | No | 07/01/20 | ||
0142A | ADM SARSCOV2 Bivalent 25MCG/0.25ML – 2nd Dose | No | 01/01/23 | ||
0142U | Nfct ds bact&fng gram neg | No | 07/01/20 | ||
0143U | Drug assay 120+ rx/metablt | No | 07/01/20 | ||
0144A | Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRN-LNP, spike protein, bivalent, preservative free, 25 mcg/0.25 mL dosage, booster dose | No | 07/01/22 | ||
0144U | Drug assay 160+ rx/metablt | No | 07/01/20 | ||
0145U | Drug assay 65+ rx/metablt | No | 07/01/20 | ||
0146U | Drug assay 80+ rx/metablt | No | 07/01/20 | ||
0147U | Drug assay 85+ rx/metablt | No | 07/01/20 | ||
0148U | Drug assay 100+ rx/metablt | No | 07/01/20 | ||
0149U | Drug assay 60+ rx/metablt | No | 07/01/20 | ||
0150U | Drug assay 120+ rx/metablt | No | 07/01/20 | ||
0151A | ADM SARSCOV2 Bivalent 10MCG/0.2ML – 1st Dose | No | 01/01/23 | ||
0151U | Nfct bct/vir resp nfctj 33 | No | 07/01/20 | ||
0152U | Nfct bct fng prst dna >1000 | No | 07/01/20 | ||
0154A | Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, booster dose | No | 07/01/22 | ||
0164A | Adm srscv2 bvl 10mcg/0.2ml b | No | 01/01/23 | ||
0171A | ADM SARSCOV2 Bivalent 3MCG/0.2ML – 1st Dose | No | 01/01/23 | ||
0172A | ADM SARSCOV2 Bivalent 3MCG/0.2ML – 2nd Dose | No | 01/01/23 | ||
0173A | Adm sarscv2 bvl 3mcg/0.2ml 3 | No | 01/01/23 | ||
0174A | Adm sarscv2 bvl 3mcg/0.2ml b | No | 01/01/23 | ||
0216T | Njx paravert w/us lumb/sac | No | 01/01/13 | ||
0217T | Njx paravert w/us lumb/sac | No | 01/01/13 | ||
0218T | Njx paravert w/us lumb/sac | No | 01/01/13 | ||
0223U | Nfct ds 22 trgt sars-cov-2 | No | 04/01/20 | ||
0224U | Antibody sars-cov-2 titer(s) | No | 04/01/20 | ||
0225U | Infectious disease (bacterial or viral respiratory tract infection) pathogen-specific DNA and RNA, 21 targets, including severe acute respiratory syndrome coronavirus 2 (SARSCoV-2), amplified probe technique, including multiplex reverse transcription for RNA targets, each analyte reported as detected or not detected | No | 07/01/20 | ||
0226U | Surrogate viral neutralization test (sVNT), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), ELISA, plasma, serum | No | 07/01/20 | ||
0227U | RX ASY PRSMV30+RX/METABLT | No | 01/01/21 | ||
0240U | Infectious disease (viral respiratory tract infection), pathogen-specific RNA, 3 targets (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2], influenza A, influenza B), upper respiratory specimen, each pathogen reported as detected or not detected | No | 07/01/20 | ||
0241U | Infectious disease (viral respiratory tract infection), pathogen-specific RNA, 4 targets (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2], influenza A, influenza B, respiratory syncytial virus [RSV]), upper respiratory specimen, each pathogen reported as detected or not detected | No | 07/01/20 | ||
0310T | Motor function mapping ntms | No | 04/01/13 | ||
0311T | Cal & alys cntrl artl press | No | 04/01/13 | ||
0500T | Hpv 5+ hi risk hpv types | No | 01/01/22 | ||
1000F | Tobacco use assessed | No | 12/01/08 | ||
4000F | Tobacco use txmnt counseling | No | 12/01/08 | ||
A4459 | Manual pump enema, reusable | No | 07/01/16 | ||
A9699 | Radiopharm rx agent noc | Yes | 01/01/23 | ||
C9055 | Injection, brexanolone, 1mg | No | 01/01/20 | 10/01/20 | |
C9137 | Adynovate Factor VIII recom | No | 07/01/16 | 01/01/17 | |
C9138 | Nuwiq Factor VIII recomb | No | 07/01/16 | 01/01/17 | |
C9140 | Afstyla factor viii recomb | No | 01/01/18 | ||
C9257 | Bevacizumab injection | No | 01/01/18 | ||
C9259 | Injection, pralatrexate, 1 mg | No | 01/01/11 | ||
C9287 | Inj, brentuximab vedotin | No | 07/01/12 | ||
C9471 | Hymovis, 1 mg | No | 07/01/16 | 01/01/17 | |
C9716 | Radiofrequency energy to anu | No | 07/01/10 | ||
C9803 | Hopd covid-19 spec collect | No | 01/01/20 | ||
D0414 | Lab process microbial spec | No | 01/01/17 | ||
D0421 | Gen tst suscept oral disease | No | 01/01/16 | ||
D0484 | Consult slides prep elsewher | No | 01/01/21 | ||
D0485 | Consult inc prep of slides | No | 01/01/21 | ||
D0600 | Non-ionizing diag proc | No | 01/01/17 | ||
D0601 | Caries risk assess low risk | No | 01/01/21 | ||
D0602 | Caries risk assess mod risk | No | 01/01/21 | ||
D0603 | Caries risk assess high risk | No | 01/01/21 | ||
D1354 | Int caries med app per tooth | No | 01/01/18 | 01/01/21 | |
D1575 | Dist space maint, fixed unil | No | 01/01/17 | 07/01/18 | |
D1999 | Unspecified preventive proc | No | 01/01/21 | ||
D4346 | Scaling gingiv inflammation | No | 01/01/17 | 07/01/18 | |
D6080 | Implant maintenance | No | 01/01/23 | ||
D6081 | Scale & debride, single imp | No | 01/01/17 | 07/01/18 | |
D6085 | Provisional implant crown | No | 01/01/17 | ||
D6092 | Recement supp crown | No | 01/01/23 | ||
D6093 | Recement supp part denture | No | 01/01/23 | ||
D6096 | Remove broken imp ret screw | No | 01/01/23 | ||
D6101 | Debridement of a periimplant | No | 01/01/23 | ||
D6102 | Debridement & contouring | No | 01/01/23 | ||
D6190 | Radio/surgical implant index | No | 01/01/23 | ||
D8695 | Remove fixed ortho appliance | No | 01/01/23 | ||
D8696 | Rep of ortho appliance max | No | 01/01/23 | ||
D8697 | Rep of ortho appliance man | No | 01/01/23 | ||
D8698 | Recement fixed retainer max | No | 01/01/23 | ||
D8699 | Recement fixed retainer man | No | 01/01/23 | ||
D8701 | Repair fixed retainer max | No | 01/01/23 | ||
D8702 | Repair of fixed retainer man | No | 01/01/23 | ||
D8703 | Replace broken retainer max | No | 01/01/23 | ||
D8704 | Replace broken retainer man | No | 01/01/23 | ||
D9210 | Dent anesthesia w/o surgery | No | 01/01/16 | ||
D9211 | Regional block anesthesia | No | 01/01/16 | ||
D9212 | Trigeminal block anesthesia | No | 01/01/16 | ||
D9215 | Local anesthesia | No | 01/01/16 | ||
D9220 | General anesthesia | No | 01/01/18 | ||
D9221 | General anesthesia ea ad 15m | No | 07/01/11 | ||
D9241 | Intravenous sedation | No | 01/01/18 | ||
D9242 | IV sedation ea ad 30 m | No | 07/01/11 | ||
D9311 | Consult w/med hlth care prof | No | 01/01/17 | ||
D9920 | Behavior management | No | 12/01/08 | 07/01/11 | 07/01/20 |
D9991 | Case mgmt, appt barriers | No | 01/01/17 | ||
D9992 | Case mgmt, care coordination | No | 01/01/17 | ||
D9993 | Case mgmt, interviewing | No | 01/01/17 | ||
D9994 | Case mgmt, pt education | No | 01/01/17 | ||
D9995 | Teledentistry real-time | No | 01/01/20 | ||
D9996 | Teledentistry dent review | No | 01/01/20 | ||
G0008 | Admin influenza virus vac | No | 10/01/09 | 04/01/11 | |
G0009 | Admin pneumococcal vaccine | No | 10/01/09 | 04/01/11 | |
G0237 | Therapeutic procd strg endur | No | 12/01/08 | ||
G0238 | Oth resp proc, indiv | No | 12/01/08 | ||
G0239 | Oth resp proc, group | No | 12/01/08 | ||
G0398 | Home sleep test/type 2 Porta | No | 01/01/13 | ||
G0399 | Home sleep test/type 3 Porta | No | 01/01/13 | ||
G0400 | Home sleep test/type 4 Porta | No | 01/01/13 | ||
G0424 | Pulmonary rehab w exer | No | 12/01/08 | 01/01/22 | |
G0464 | Colorec ca scr, sto bas dna | No | 01/01/16 | ||
G0493 | Rn care ea 15 min hh/hospice | No | 01/01/17 | ||
G0494 | Lpn care ea 15min hh/hospice | No | 01/01/17 | ||
G0495 | Rn care train/edu in hh | No | 01/01/17 | ||
G0496 | Lpn care train/edu in hh | No | 01/01/17 | ||
G2025 | Dis site tele svcs rhc/fqhc | No | 01/01/20 | ||
G8402 | Smoke preven interven counse | No | 12/01/08 | ||
G8403 | Smoke preven Outcounsel | No | 12/01/08 | ||
G9013 | Esrd demo bundle level i | No | 01/01/20 | ||
G9014 | Esrd demo bundle-level ii | No | 01/01/20 | ||
G9016 | Demo-smoking cessation coun | No | 12/01/08 | ||
G9141 | Influenza A (H1N1) - administration | No | 10/01/09 | 07/01/11 | |
G9142 | Influenza A (H1N1) - vaccine | No | 10/01/09 | 07/01/11 | |
G9143 | Warfarin respon genetic test | No | 01/01/16 | ||
G9481 | Remote E/M new pt 10mins | No | 07/01/16 | ||
G9482 | Remote E/M new pt 20mins | No | 07/01/16 | ||
G9483 | Remote E/M new pt 30mins | No | 07/01/16 | ||
G9484 | Remote E/M new pt 45mins | No | 07/01/16 | ||
G9485 | Remote E/M new pt 60mins | No | 07/01/16 | ||
G9486 | Remote E/M est. pt 10mins | No | 07/01/16 | ||
G9487 | Remote E/M est. pt 15mins | No | 07/01/16 | ||
G9488 | Remote E/M est. pt 25mins | No | 07/01/16 | ||
G9489 | Remote E/M est. pt 40mins | No | 07/01/16 | ||
G9490 | Joint replac mod home visit | No | 07/01/16 | ||
G9678 | Oncology Care Model service | No | 07/01/16 | ||
G9919 | Scrn nd pos nd prov of rec | No | 01/01/24 | ||
G9920 | Scrning perf and negative | No | 01/01/24 | ||
H0018 | Alcohol and/or drug services | No | 07/01/10 | ||
H0023 | Behavioral health outreach service - planned approach to reach a targeted population | No | 10/01/10 | ||
H0031 | Mh health assess by non-md | No | 01/01/20 | ||
H0032 | MH svc plan dev by non-md | No | 07/01/10 | ||
H0037 | Comm psy sup tx pgm per diem | No | 07/01/10 | ||
H0046 | Mental health service, nos | No | 01/01/20 | ||
H2029 | Sex offend tx svc, per diem | No | 07/01/10 | ||
J0128 | Injection, abarelix, 10 mg | No | 01/01/11 | ||
J0207 | Amifostine | Yes | 07/01/21 | ||
J0365 | Injection, aprotonin, 10,000 kiu | No | 01/01/11 | ||
J0480 | Injection, basiliximab, 20 mg | No | 01/01/11 | ||
J0585 | Botulinum toxin a per unit | Yes | 12/01/08 | 01/01/15 | |
J0587 | Botulinum toxin type B | Yes | 12/01/08 | ||
J0740 | Injection, cidofovir, 375 mg | Yes | 01/01/11 | ||
J0882 | Darbepoetin alfa, esrd use | Yes | 12/01/08 | 01/01/12 | |
J0886 | Epoetin alfa 1000 units ESRD | No | 12/01/08 | 01/01/12 | 10/01/13 |
J0890 | Peginesatide injection | No | 07/01/13 | ||
J0894 | Decitabine injection | Yes | 01/01/22 | ||
J1322 | Elosulfase alfa, injection | Yes | 01/01/22 | ||
J1440 | Filgrastim 300 mcg injection | Yes | 12/01/08 | 01/01/14(1) | |
J1441 | Filgrastim 480 mcg injection | No | 12/01/08 | ||
J1442 | Inj filgrastim excl biosimil | Yes | 01/01/18 | ||
J1566 | Injection, immune globulin, intravenous, lyophilized (e.g. powder), not otherwise specified, 500 mg | Yes | 01/01/11 | ||
J1675 | Injection, histrelin acetate, 10 micrograms | No | 01/01/11 | ||
J1725 | Hydroxyprogesterone caproate | No | 04/01/12 | ||
J1726 | Makena, 10 mg | Yes | 01/01/18 | ||
J1931 | Injection, laronidase, 0.1 mg | No | 01/01/11 | ||
J1950 | Leuprolide acetate /3.75 mg | Yes | 01/01/22 | ||
J2315 | Naltrexone, depot form | Yes - Only for Article 32 providers | 01/01/10 | 07/01/11 | |
J2323 | Natalizumab injection | Yes - only for TOUCH providers | 01/01/10 | 01/01/11 | |
J2358 | Olanzapine long-acting inj | Yes | 04/01/11 | ||
J2426 | Paliperidone palmitate inj | Yes | 04/01/11 | ||
J2505 | Injection, pegfilgrastim 6mg | No | 12/01/08 | ||
J2506 | Inj pegfilgrast ex bio 0.5mg | Yes | 01/01/22 | ||
J2562 | Injection, plerixafor, 1 mg | Yes | 01/01/11 | ||
J2783 | Rasburicase | Yes | 01/01/21 | ||
J2794 | Risperidone, long acting | Yes | 04/01/09 | ||
J2997 | Alteplase recombinant | Yes | 04/01/10 | 04/01/11 | |
J3110 | Injection, teriparatide, 10 mcg | Yes | 01/01/11 | ||
J3285 | Injection, treprostinil, 1 mg | Yes | 01/01/11 | ||
J3316 | Inj., triptorelin xr 3.75 mg | Yes | 01/01/22 | ||
J3490 | Drugs unclassified injection | Yes | 04/01/10 | ||
J3590 | Unclassified biologics | Yes | 04/01/10 | ||
J7175 | Inj, factor x, (human), 1iu | Yes | 01/01/18 | ||
J7178 | Human fibrinogen conc inj | No | 01/01/18 | ||
J7179 | Vonvendi inj 1 iu vwf:rco | Yes | 01/01/18 | ||
J7180 | Factor xiii anti-hem factor | Yes | 01/01/21 | ||
J7181 | Factor xiii recomb a-subunit | Yes | 01/01/18 | ||
J7182 | Factor viii recomb novoeight | Yes | 01/01/18 | ||
J7183 | Wilate injection | No | 01/01/18 | ||
J7185 | Xyntha inj | Yes | 01/01/18 | ||
J7186 | Antihemophilic viii/vwf comp | Yes | 01/01/18 | ||
J7187 | Humate-P, inj | Yes | 12/01/08 | ||
J7188 | Factor viii recomb obizur | Yes | 01/01/18 | ||
J7189 | Factor viia | Yes | 12/01/08 | ||
J7190 | Factor viii | Yes | 12/01/08 | ||
J7191 | Factor VIII (porcine) | Yes | 12/01/08 | ||
J7192 | Factor viii recombinant | Yes | 12/01/08 | ||
J7193 | Factor IX No - APG Carve Outn-recombinant | Yes | 12/01/08 | ||
J7194 | Factor ix complex | Yes | 12/01/08 | ||
J7195 | Factor IX recombinant | Yes | 12/01/08 | ||
J7196 | Antithrombin recombinant | No | 01/01/18 | ||
J7197 | Antithrombin iii injection | Yes | 12/01/08 | ||
J7198 | Anti-inhibitor | Yes | 12/01/08 | ||
J7199 | Hemophilia clot factor No - APG Carve Outc | Yes | 12/01/08 | ||
J7200 | Factor ix recombinan rixubis | Yes | 01/01/18 | ||
J7201 | Factor ix alprolix recomb | Yes | 01/01/18 | ||
J7202 | Factor ix idelvion inj | Yes | 01/01/18 | ||
J7203 | Factor ix recomb gly rebinyn | No | 01/01/21 | ||
J7204 | Inj recombin esperoct per iu | Yes | 01/01/21 | ||
J7205 | Factor viii fc fusion recomb | Yes | 01/01/18 | ||
J7207 | Factor viii pegylated recomb | Yes | 01/01/18 | ||
J7208 | Inj. jivi 1 iu | Yes | 01/01/21 | ||
J7209 | Factor viii nuwiq recomb 1iu | Yes | 01/01/18 | ||
J7210 | Inj, afstyla, 1 i.u. | Yes | 01/01/21 | ||
J7211 | Inj, kovaltry, 1 i.u. | Yes | 01/01/21 | ||
J7294 | Seg acet and eth estr yearly | Yes | 01/01/22 | ||
J7295 | Eth estr and eton monthly | Yes | 01/01/22 | ||
J7296 | Kyleena, 19.5 mg | Yes | 01/01/18 | ||
J7297 | Levonorgestrel iu 52mg 3 yr | Yes | 07/01/16 | ||
J7298 | Levonorgestrel iu 52mg 5 yr | Yes | 07/01/16 | ||
J7300 | Intraut copper contraceptive | Yes | 12/01/08 | ||
J7301 | Levonorgestrel iu 13.5 mg | Yes | 07/01/16 | ||
J7302 | LevoNo - APG Carve Outrgestrel iu contracept | No | 12/01/08 | ||
J7306 | Levonorgestrel implant sys | Yes | 07/01/16 | ||
J7307 | EtoNo - APG Carve Outgestrel implant system | Yes | 12/01/08 | ||
J7311 | Inj., retisert, 0.01 mg | Yes | 07/01/21 | ||
J7320 | Genvisc 850, inj, 1mg | No | 01/01/17 | ||
J7322 | Hymovis injection 1 mg | No | 01/01/17 | ||
J8520 | Capecitabine, oral, 150 mg | No | 01/01/11 | ||
J9001 | Injection, doxorubicin hydrochloride, all lipid formulations, 10 mg | No | 01/01/11 | ||
J9019 | Erwinaze injection | Yes | 07/01/14 | ||
J9022 | Inj, atezolizumab,10 mg | Yes | 01/01/21 | ||
J9023 | Injection, avelumab, 10 mg | Yes | 01/01/21 | ||
J9027 | Clofarabine injection | Yes | 12/01/08 | ||
J9032 | Injection, belinostat, 10mg | Yes | 01/01/21 | ||
J9033 | Injection, bendamustine hcl, 1 mg | Yes | 01/01/11 | ||
J9034 | Inj., bendeka 1 mg | Yes | 01/01/21 | ||
J9035 | Injection, bevacizumab, 10 mg | Yes | 01/01/11 | ||
J9036 | Inj. belrapzo/bendamustine | Yes | 01/01/21 | ||
J9039 | Injection, blinatumomab | Yes | 01/01/18 | ||
J9042 | Brentuximab vedotin inj | Yes | 01/01/21 | ||
J9043 | Cabazitaxel injection | Yes | 01/01/21 | ||
J9044 | Inj, bortezomib, nos, 0.1 mg | No | 01/01/21 | ||
J9047 | Injection, carfilzomib, 1 mg | Yes | 01/01/21 | ||
J9050 | Carmustine injection | Yes | 01/01/21 | ||
J9055 | Injection, cetuximab, 10 mg | Yes | 01/01/11 | ||
J9057 | Inj., copanlisib, 1 mg | Yes | 01/01/21 | ||
J9061 | Inj, amivantamab-vmjw | Yes | 01/01/22 | ||
J9098 | Injection, cytarabine liposome, 10 mg | Yes | 01/01/11 | ||
J9118 | Inj. Calaspargase pegol-mknl | Yes | 01/01/21 | ||
J9119 | Inj., cemiplimab-rwlc, 1 mg | Yes | 01/01/21 | ||
J9120 | Injection, dactinomycin, 0.5 mg | Yes | 01/01/11 | ||
J9145 | Injection, daratumumab 10 mg | Yes | 01/01/21 | ||
J9153 | Inj daunorubicin, cytarabine | Yes | 01/01/21 | ||
J9160 | Injection, denileukin diftitox, 300 micrograms | No | 01/01/11 | ||
J9173 | Inj., durvalumab, 10 mg | Yes | 01/01/21 | ||
J9176 | Injection, elotuzumab, 1mg | Yes | 01/01/21 | ||
J9177 | Inj enfort vedo-ejfv 0.25mg | Yes | 01/01/21 | ||
J9202 | Goserelin acetate implant | Yes | 01/01/18 | ||
J9203 | Gemtuzumab ozogamicin 0.1 mg | Yes | 01/01/21 | ||
J9204 | Inj mogamulizumab-kpkc, 1 mg | Yes | 01/01/21 | ||
J9205 | Inj irinotecan liposome 1 mg | Yes | 01/01/21 | ||
J9207 | Injection, ixabepilone, 1 mg | Yes | 01/01/11 | ||
J9210 | Inj., emapalumab-lzsg, 1 mg | Yes | 01/01/21 | ||
J9219 | Leuprolide acetate implant, 65 mg | Yes | 01/01/11 | ||
J9223 | Inj. lurbinectedin, 0.1 mg | Yes | 01/01/24 | ||
J9225 | Histrelin implant (vantas), 50 mg | Yes | 01/01/11 | ||
J9226 | Supprelin LA implant | Yes | 10/01/10 | ||
J9227 | Inj. isatuximab-irfc 10 mg | Yes | 01/01/21 | ||
J9228 | Ipilimumab injection | Yes | 01/01/21 | ||
J9229 | Inj inotuzumab ozogam 0.1 mg | Yes | 01/01/21 | ||
J9245 | Injection, melphalan hydrochloride, 50 mg | Yes | 01/01/11 | ||
J9246 | Inj., evomela, 1 mg | Yes | 01/01/21 | ||
J9261 | Nelarabine injection | Yes | 01/01/21 | ||
J9263 | Injection, oxaliplatin, 0.5 mg | Yes | 01/01/11 | ||
J9264 | Injection, paclitaxel protein-bound particles, 1 mg | Yes | 01/01/11 | ||
J9266 | Injection, pegaspargase, per single dose vial | Yes | 01/01/11 | ||
J9268 | Injection, pentostatin, 10 mg | Yes | 01/01/11 | ||
J9269 | Inj. tagraxofusp-erzs 10 mcg | Yes | 01/01/21 | ||
J9271 | Inj pembrolizumab | Yes | 01/01/18 | ||
J9272 | Inj, dostarlimab-gxly, 10 mg | Yes | 01/01/22 | ||
J9280 | Mitomycin injection | Yes | 07/01/21 | ||
J9285 | Inj, olaratumab, 10 mg | Yes | 01/01/21 | ||
J9295 | Injection, necitumumab, 1 mg | Yes | 01/01/21 | ||
J9299 | Injection, nivolumab | Yes | 01/01/18 | ||
J9301 | Obinutuzumab inj | Yes | 01/01/18 | ||
J9302 | Ofatumumab injection | Yes | 01/01/21 | ||
J9303 | Injection, panitumumab, 10 mg | Yes | 01/01/11 | ||
J9305 | Injection, pemetrexed, 10 mg | Yes | 01/01/11 | ||
J9307 | Pralatrexate injection | Yes | 01/01/18 | ||
J9308 | Injection, ramucirumab | Yes | 01/01/18 | ||
J9309 | Inj, polatuzumab vedotin 1mg | Yes | 01/01/21 | ||
J9310 | Injection, rituximab, 100 mg | No | 01/01/11 | ||
J9311 | Inj rituximab, hyaluronidase | Yes | 01/01/21 | ||
J9312 | Inj., rituximab, 10 mg | Yes | 01/01/21 | ||
J9313 | Inj., lumoxiti, 0.01 mg | Yes | 01/01/21 | ||
J9325 | Inj talimogene laherparepvec | Yes | 01/01/21 | ||
J9328 | Temozolomide injection | Yes | 01/01/21 | ||
J9350 | Injection, topotecan, 4 mg | Yes | 01/01/11 | ||
J9352 | Injection trabectedin 0.1mg | Yes | 01/01/21 | ||
J9354 | Inj, ado-trastuzumab emt 1mg | Yes | 01/01/18 | ||
J9355 | Injection, trastuzumab, 10 mg | Yes | 01/01/11 | ||
J9356 | Inj. herceptin hylecta, 10mg | Yes | 01/01/21 | ||
J9357 | Valrubicin injection | Yes | 01/01/21 | ||
J9358 | Inj fam-trastu deru-nxki 1mg | Yes | 01/01/21 | ||
J9371 | Inj, vincristine sul lip 1mg | Yes | 01/01/21 | ||
J9400 | Inj, ziv-aflibercept, 1mg | Yes | 01/01/18 | ||
J9600 | Injection, porfimer sodium, 75 mg | Yes | 01/01/11 | ||
M0075 | Cellular therapy | No | 01/01/22 | ||
M0201 | Covid-19 vaccine home admin | No | 01/01/21 | ||
M0220 | Tixagev and cilgav inj | No as of 1/26/23 | 01/01/22 | ||
M0221 | Tixagev and cilgav inj hm | No | 01/01/22 | ||
M0222 | Bebtelovimab injection | No | 01/01/22 | ||
M0223 | Bebtelovimab injection home | No | 01/01/22 | ||
M0239 | Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring | No | 01/01/21 | ||
M0240 | Casiri and imdev repeat | No | 07/01/21 | ||
M0241 | Casiri and imdev repeat hm | No | 07/01/21 | ||
M0243 | Casirivi and imdevi infusion | No | 01/01/21 | ||
M0244 | Casirivi and imdevi inj hm | No | 01/01/21 | ||
M0245 | Bamlan and etesev infusion | No | 01/01/21 | ||
M0246 | Bamlan and etesev infus home | No | 01/01/21 | ||
M0247 | Sotrovimab infusion | No | 01/01/21 | ||
M0248 | Sotrovimab inf, home admin | No | 01/01/21 | ||
M0249 | Adm Tocilizu COVID-19 1st | No | 01/01/21 | ||
M0250 | Adm Tocilizu COVID-19 2nd | No | 01/01/21 | ||
M0301 | Fabric wrapping of aneurysm | No | 01/01/22 | ||
P9099 | Blood component/product noc | No | 07/01/20 | ||
P9603 | One-way allow prorated miles | No | 01/01/20 | ||
P9604 | One-way allow prorated trip | No | 01/01/20 | ||
Q0091 | Obtaining screen pap smear | No | 01/01/12 | ||
Q0220 | Tixagev and cilgav inj | No as of 1/26/23 | 01/01/22 | ||
Q0221 | Tixagev and cilgav, 600mg | No as of 1/26/23 | 01/01/22 | ||
Q0222 | Bebtelovimab 175 mg | No | 01/01/22 | ||
Q0239 | Injection, bamlanivimab, 700 mg | No | 01/01/21 | ||
Q0240 | Casirivi and imdevi 600mg | No | 07/01/21 | ||
Q0243 | Casirivimab and imdevimab | No | 01/01/21 | ||
Q0244 | Casirivi and imdevi 1200 mg | No | 01/01/21 | ||
Q0245 | Bamlanivimab and etesevima | No | 01/01/21 | ||
Q0247 | Sotrovimab | No | 01/01/21 | ||
Q0249 | Tocilizumab for COVID-19 | No | 01/01/21 | ||
Q2017 | Teniposide, 50 mg | Yes | 01/01/21 | ||
Q2043 | Provenge | Yes | 07/01/14 | ||
Q2049 | Imported lipodox inj | No | 01/01/16 | ||
Q2050 | Doxorubicin inj 10mg | Yes | 01/01/18 | ||
Q4074 | Iloprost, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 20 micrograms | No | 01/01/11 | ||
Q5108 | Injection, fulphila | No | 01/01/21 | ||
Q5111 | Injection, udenyca 0.5 mg | Yes | 01/01/21 | ||
Q5112 | Inj ontruzant 10 mg | Yes | 01/01/21 | ||
Q5113 | Inj herzuma 10 mg | Yes | 01/01/21 | ||
Q5114 | Inj ogivri 10 mg | Yes | 01/01/21 | ||
Q5115 | Inj truxima 10 mg | Yes | 01/01/21 | ||
Q5116 | Inj., trazimera, 10 mg | Yes | 01/01/21 | ||
Q5117 | Inj., kanjinti, 10 mg | Yes | 01/01/21 | ||
Q5118 | Inj., zirabev, 10 mg | Yes | 01/01/22 | ||
Q5119 | Inj ruxience, 10 mg | Yes | 01/01/21 | ||
Q5120 | Inj pegfilgrastim-bmez 0.5mg | Yes | 01/01/21 | ||
S0013 | Esketamine, nasal spray | Yes | 01/01/23 | ||
S0166 | Inj olanzapine 2.5mg | No | 04/01/11 | ||
S0189 | Testosterone pellet 75 mg | Yes | 01/01/24 | ||
S0190 | Mifepristone, oral, 200 mg | Yes | 12/01/08 | ||
S0191 | Misoprostol, oral, 200 mcg | Yes | 12/01/08 | ||
S0199 | Med abortion inc all ex drug | No | 01/01/20 | ||
S2070 | Cysto laser tx ureteral calc | No | 01/01/22 | ||
S2079 | Lap esophagomyotomy | No | 01/01/22 | ||
S2080 | Laup | No | 01/01/22 | ||
S2095 | Transcath emboliz microspher | No | 01/01/22 | ||
S2102 | Islet cell tissue transplant | No | 01/01/22 | ||
S2107 | Adoptive immunotherapy | No | 01/01/22 | ||
S2115 | Periacetabular osteotomy | No | 01/01/22 | ||
S2117 | Arthroereisis, subtalar | No | 01/01/22 | ||
S2120 | Low density lipoprotein(ldl) | No | 01/01/22 | ||
S2150 | Bmt harv/transpl 28d pkg | No | 01/01/22 | ||
S2202 | Echosclerotherapy | No | 01/01/20 | ||
S3800 | Genetic testing als | No | 01/01/16 | ||
S3818 | BRCA1 gene anal | No | 01/01/10 | ||
S3819 | BRCA2 gene anal | No | 01/01/10 | ||
S3820 | Comp BRCA1/BRCA2 | No | 01/01/10 | ||
S3822 | Sing mutation brst/ovar | No | 01/01/10 | ||
S3823 | 3 mutation brst/ovar | No | 01/01/10 | ||
S3828 | Comp MLH1 gene | No | 01/01/10 | ||
S3829 | Comp MLH2 gene | No | 01/01/10 | ||
S3830 | Gene test HNPCC comp | No | 01/01/10 | ||
S3831 | Gene test HNPCC single | No | 01/01/10 | ||
S3833 | Comp APC sequence | No | 01/01/10 | ||
S3834 | Sing mutation APC | No | 01/01/10 | ||
S3835 | Gene test cystic fibrosis | No | 01/01/10 | ||
S3840 | DNA analysis RET-oncogene | No | 01/01/10 | ||
S3841 | Gene test retinoblastoma | No | 01/01/16 | ||
S3842 | Gene test Hippel-Lindau | No | 01/01/10 | ||
S3843 | DNA analysis factor v | No | 01/01/10 | ||
S3844 | DNA analysis deafness | No | 01/01/10 | ||
S3845 | Gene test alpha-thalassemia | No | 01/01/10 | ||
S3846 | Gene test beta-thalassemia | No | 01/01/10 | ||
S3847 | Gene test Tay-Sachs | No | 01/01/10 | ||
S3848 | Gene test Gaucher | No | 01/01/10 | ||
S3849 | Gene test Niemann-Pick | No | 01/01/10 | ||
S3850 | Gene test sickle cell | No | 01/01/10 | ||
S3851 | Gene test canavan | No | 01/01/10 | ||
S3852 | DNA analysis APOE alzheimer | No | 01/01/10 | ||
S3853 | Gene test myo musclr dyst | No | 01/01/10 | ||
S3854 | Gene profile panel breast | No | 01/01/16 | ||
S3861 | Genetic test brugada | No | 01/01/16 | ||
S3865 | Comp genet test hyp cardiomy | No | 01/01/16 | ||
S3866 | Spec gene test hyp cardiomy | No | 01/01/16 | ||
S3870 | Cgh test developmental delay | No | 01/01/16 | ||
S3890 | Fecal dna analysis | No | 01/01/16 | ||
S4026 | Procure donor sperm | No | 07/01/21 | ||
S4027 | Store prev froz embryos | No | 07/01/21 | ||
S4040 | Monit store cryo embryo 30 d | No | 07/01/21 | ||
S4989 | Contracept IUD | No | 12/01/08 | ||
S8940 | Hippotherapy per session | No | 12/01/08 | ||
S9055 | Procuren or other growth fac | No | 01/01/22 | ||
S9075 | Smoking cessation treatment | No | 12/01/08 | ||
S9128 | Speech therapy, in the home, | No | 12/01/08 | ||
S9129 | Occupational therapy, in the | No | 12/01/08 | ||
S9131 | PT in the home per diem | No | 12/01/08 | ||
S9453 | Smoking cessation class | No | 12/01/08 | ||
S9473 | Pulmonary rehabilitation pro | No | 12/01/08 | ||
S9480 | Intensive outpatient psychia | No | 07/01/10 | 01/01/11 | |
S9529 | Venipuncture home/snf | No | 01/01/20 | ||
T1040 | Comm bh clinic svc per diem | No | 01/01/17 | ||
T1041 | Comm bh clinic svc per month | No | 01/01/17 | ||
U0002 | Covid-19 lab test non-cdc | Yes | 01/01/20 | ||
U0003 | Infectious agent detection | No | 04/01/20 | ||
U0004 | 2019-nCoV Coronavirus, SARS | No | 04/01/20 | ||
U0005 | Infec agen detec ampli probe | No | 01/01/22 | ||
V5014 | Hearing aid repair/modifying | No | 04/01/12 | ||
V5362 | Speech screening | No | 04/01/11 | ||
V5364 | Dysphagia screening | No | 04/01/11 |
1. J1440 (Filgrastim 300 mcg injection) was end-dated as of 12/31/2013, however, a new J1440 (Fecal microbiota jslm 1 ml) becomes active effective 7/1/2023, which is not added to the Never Pay Procedures list. 1
Yes = Procedure code is not payable in APGs but is available for billing on ordered ambulatory fee schedule.
No = Procedure code is not reimbursable by Medicaid. Service may be billable under an alternative procedure code.